-
EP4192872
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4192872
| EP4192872 - PROTEINS BINDING NKG2D, CD16 AND EGFR [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 09.05.2023 Database last updated on 29.10.2024 | |
| Former | The international publication has been made Status updated on 11.02.2022 | ||
| Former | unknown Status updated on 07.09.2021 | Most recent event Tooltip | 27.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Dragonfly Therapeutics, Inc. 180 3rd Avenue, Sixth Floor Waltham, MA 02451 / US | [2024/26] |
| Former [2023/24] | For all designated states Dragonfly Therapeutics, Inc. 35 Gatehouse Drive Waltham, MA 02451 / US | Inventor(s) | 01 /
CHEUNG, Ann, F. Lincoln, MA 01773 / US | 02 /
DRABIC, Stacey, V. Cambridge, MA 02140 / US | 03 /
GRINBERG, Asya Lexington, MA 02421 / US | 04 /
JUO, Zong, Sean Taipei, 114 / TW | 05 /
LIHARSKA, Katia Billerica, MA 01821 / US | 06 /
MORGAN, Christopher, Ryan Southborough, MA 01772 / US | 07 /
WAGTMANN, Nicolai Concord, MA 01742 / US | [2023/24] | Representative(s) | Haseltine Lake Kempner LLP Cheapside House 138 Cheapside London EC2V 6BJ / GB | [2023/24] | Application number, filing date | 21762272.9 | 05.08.2021 | [2023/24] | WO2021US44737 | Priority number, date | US202063061510P | 05.08.2020 Original published format: US 202063061510 P | [2023/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022031965 | Date: | 10.02.2022 | Language: | EN | [2022/06] | Type: | A1 Application with search report | No.: | EP4192872 | Date: | 14.06.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.02.2022 takes the place of the publication of the European patent application. | [2023/24] | Search report(s) | International search report - published on: | EP | 10.02.2022 | Classification | IPC: | C07K16/28, A61P35/00, C07K14/705 | [2023/24] | CPC: |
C07K16/2863 (EP,IL,US);
C07K16/2851 (US);
A61P35/00 (EP,IL,US);
C07K16/283 (EP,IL,US);
C07K2317/35 (EP,IL);
C07K2317/524 (US);
C07K2317/55 (US);
C07K2317/565 (US);
C07K2317/622 (EP,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/24] | Extension states | BA | 03.03.2023 | ME | 03.03.2023 | Validation states | KH | 03.03.2023 | MA | 03.03.2023 | MD | 03.03.2023 | TN | 03.03.2023 | Title | German: | PROTEINE, DIE NKG2D, CD16 UND EGFR BINDEN | [2023/24] | English: | PROTEINS BINDING NKG2D, CD16 AND EGFR | [2023/24] | French: | PROTÉINES SE LIANT À NKG2D, CD16 ET EGFR | [2023/24] | Entry into regional phase | 03.03.2023 | National basic fee paid | 03.03.2023 | Designation fee(s) paid | 03.03.2023 | Examination fee paid | Examination procedure | 03.03.2023 | Amendment by applicant (claims and/or description) | 03.03.2023 | Examination requested [2023/24] | 03.03.2023 | Date on which the examining division has become responsible | 08.05.2023 | Despatch of a communication from the examining division (Time limit: M04) | 18.09.2023 | Reply to a communication from the examining division | 07.11.2024 | Date of oral proceedings | Fees paid | Renewal fee | 03.03.2023 | Renewal fee patent year 03 | 27.08.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2015184203 (MACROGENICS INC [US]); | [Y]WO2019035939 (DRAGONFLY THERAPEUTICS INC [US]); | by applicant | WO2015095412 | WO2016134371 | WO2018148445 | WO2019157366 | US20090811207 | US20090533709 | US20100875015 |